MED logo

Medifast (MED) Shareholders Equity

Annual Shareholders Equity

$210.11 M
+$8.63 M+4.28%

December 31, 2024

Summary

Performance

1-Year Change

+4.28%

3-Year Change

+3.77%

5-Year Change

+100.42%

15-Year Change

+93.5%

MED Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.89%
MED annual stockholders equity is higher than 46.89% of companies in Consumer Cyclical sector

High & Low

All-time High

$210.11 M
MED annual stockholders equity is currently at an all-time high

3-Year Low

$155.04 M
MED annual stockholders equity is currently +35.52% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
MED previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
MED next annual earnings announcement has not yet been scheduled

OtherMEDbalance sheetmetrics:

Annual Retained Earnings

$176.78 M
MED annual retained earnings is $176.78 million

Annual Working Capital

$150.24 M
MED annual working capital is $150.24 million

Annual Total Assets

$284.21 M
MED annual total assets is $284.21 million

Annual Total Liabilities

$74.10 M
MED annual total liabilities is $74.10 million

Quarterly Shareholders Equity

$210.11 M
+$2.77 M+1.33%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

+100.42%

MED Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.97%
MED quarterly stockholders equity is higher than 47.97% of companies in Consumer Cyclical sector

High & Low

All-time High

$216.02 M
MED quarterly stockholders equity is currently -2.74% below its historical high of $216.02 million

3-Year Low

$129.48 M
MED quarterly stockholders equity is currently +62.28% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
MED previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 29, 2025
MED next earnings announcement is scheduled for Apr 29, 2025

OtherMEDbalance sheetmetrics:

Quarterly Retained Earnings

$176.78 M
MED quarterly retained earnings is $176.78 million

Quarterly Working Capital

$150.24 M
MED quarterly working capital is $150.24 million

Quarterly Total Assets

$284.21 M
MED quarterly total assets is $284.21 million

Quarterly Total Liabilities

$74.10 M
MED quarterly total liabilities is $74.10 million

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

Annual Shareholders Equity

$210.11 M
MED annual stockholders equity is $210.11 million

Annual Total Assets

$284.21 M
MED annual total assets is $284.21 million

Annual Total Liabilities

$74.10 M
MED annual total liabilities is $74.10 million

MED Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.3%0.0%
3 y3 years+3.8%0.0%
5 y5 years+100.4%+100.4%

MED Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+35.5%-2.7%+62.3%
5 y5-yearat high+100.4%-2.7%+100.4%
alltimeall timeat high>+9999.0%-2.7%>+9999.0%

Medifast Shareholders Equity History

DateAnnualQuarterly
Dec 2024
$210.11 M(+4.3%)
$210.11 M(+1.3%)
Sep 2024
-
$207.34 M(+1.0%)
Jun 2024
-
$205.28 M(-2.7%)
Mar 2024
-
$210.96 M(+4.7%)
Dec 2023
$201.48 M(+30.0%)
$201.48 M(+4.4%)
Sep 2023
-
$193.03 M(+4.0%)
Jun 2023
-
$185.56 M(+8.6%)
Mar 2023
-
$170.90 M(+10.2%)
Dec 2022
$155.04 M(-23.4%)
$155.04 M(+3.0%)
Sep 2022
-
$150.52 M(+16.3%)
Jun 2022
-
$129.48 M(-40.1%)
Mar 2022
-
$216.02 M(+6.7%)
Dec 2021
$202.47 M(+28.8%)
$202.47 M(+3.2%)
Sep 2021
-
$196.24 M(+0.8%)
Jun 2021
-
$194.69 M(+11.3%)
Mar 2021
-
$174.89 M(+11.2%)
Dec 2020
$157.25 M(+50.0%)
$157.25 M(+12.3%)
Sep 2020
-
$140.01 M(+19.9%)
Jun 2020
-
$116.74 M(+5.4%)
Mar 2020
-
$110.75 M(+5.6%)
Dec 2019
$104.83 M(-3.9%)
$104.83 M(-5.7%)
Sep 2019
-
$111.20 M(-11.8%)
Jun 2019
-
$126.02 M(+3.2%)
Mar 2019
-
$122.07 M(+11.9%)
Dec 2018
$109.11 M(+0.5%)
$109.11 M(-2.3%)
Sep 2018
-
$111.64 M(+8.5%)
Jun 2018
-
$102.86 M(-9.5%)
Mar 2018
-
$113.63 M(+4.6%)
Dec 2017
$108.58 M(+13.1%)
$108.58 M(+0.3%)
Sep 2017
-
$108.21 M(+3.9%)
Jun 2017
-
$104.17 M(+5.0%)
Mar 2017
-
$99.17 M(+3.3%)
Dec 2016
$96.02 M(+8.4%)
$96.02 M(+1.1%)
Sep 2016
-
$94.93 M(+4.0%)
Jun 2016
-
$91.27 M(+1.6%)
Mar 2016
-
$89.86 M(+1.4%)
Dec 2015
$88.58 M(+10.1%)
$88.58 M(+2.0%)
Sep 2015
-
$86.81 M(-1.6%)
Jun 2015
-
$88.20 M(+4.0%)
Mar 2015
-
$84.83 M(+5.4%)
Dec 2014
$80.48 M(-18.2%)
$80.48 M(-2.5%)
Sep 2014
-
$82.55 M(-15.3%)
Jun 2014
-
$97.51 M(-7.3%)
Mar 2014
-
$105.17 M(+6.9%)
Dec 2013
$98.42 M(+8.4%)
$98.42 M(-11.6%)
Sep 2013
-
$111.34 M(+6.5%)
Jun 2013
-
$104.55 M(+7.4%)
Mar 2013
-
$97.31 M(+7.2%)
Dec 2012
$90.79 M(+23.7%)
$90.79 M(+4.1%)
Sep 2012
-
$87.23 M(+9.9%)
Jun 2012
-
$79.40 M(+1.7%)
Mar 2012
-
$78.10 M(+6.4%)
DateAnnualQuarterly
Dec 2011
$73.40 M(+2.0%)
$73.40 M(+2.6%)
Sep 2011
-
$71.55 M(-3.3%)
Jun 2011
-
$74.03 M(-6.8%)
Mar 2011
-
$79.46 M(+10.4%)
Dec 2010
$71.96 M(+50.5%)
$71.96 M(+4.3%)
Sep 2010
-
$68.98 M(+11.5%)
Jun 2010
-
$61.85 M(+11.8%)
Mar 2010
-
$55.30 M(+15.7%)
Dec 2009
$47.82 M(+35.8%)
$47.82 M(-1.3%)
Sep 2009
-
$48.44 M(+7.8%)
Jun 2009
-
$44.94 M(+9.7%)
Mar 2009
-
$40.98 M(+16.4%)
Dec 2008
$35.22 M(+8.6%)
$35.22 M(-4.9%)
Sep 2008
-
$37.02 M(+4.3%)
Jun 2008
-
$35.51 M(+5.2%)
Mar 2008
-
$33.74 M(+4.1%)
Dec 2007
$32.42 M(+16.1%)
$32.42 M(+2.3%)
Sep 2007
-
$31.69 M(+4.3%)
Jun 2007
-
$30.39 M(+2.7%)
Mar 2007
-
$29.58 M(+6.0%)
Dec 2006
$27.92 M(+26.8%)
$27.92 M(+2.4%)
Sep 2006
-
$27.25 M(+6.7%)
Jun 2006
-
$25.53 M(+7.5%)
Mar 2006
-
$23.74 M(+7.8%)
Dec 2005
$22.02 M(+14.7%)
$22.02 M(+3.6%)
Sep 2005
-
$21.26 M(+3.2%)
Jun 2005
-
$20.60 M(+4.3%)
Mar 2005
-
$19.75 M(+2.8%)
Dec 2004
$19.21 M(+12.5%)
$19.21 M(+2.1%)
Sep 2004
-
$18.81 M(+2.2%)
Jun 2004
-
$18.41 M(+3.5%)
Mar 2004
-
$17.78 M(+4.1%)
Dec 2003
$17.08 M(+206.1%)
$17.08 M(+13.0%)
Sep 2003
-
$15.11 M(+84.9%)
Jun 2003
-
$8.17 M(+24.0%)
Mar 2003
-
$6.59 M(+18.1%)
Dec 2002
$5.58 M(+119.8%)
$5.58 M(+5.7%)
Sep 2002
-
$5.28 M(+46.9%)
Jun 2002
-
$3.59 M(+22.4%)
Mar 2002
-
$2.94 M(+15.7%)
Dec 2001
$2.54 M(+109.8%)
$2.54 M(+24.1%)
Sep 2001
-
$2.04 M(+28.6%)
Jun 2001
-
$1.59 M(+9.2%)
Mar 2001
-
$1.46 M(+20.3%)
Dec 2000
$1.21 M(-668.1%)
$1.21 M(+23.7%)
Sep 2000
-
$978.30 K(+17.5%)
Jun 2000
-
$832.60 K(+37.6%)
Mar 2000
-
$605.00 K
Dec 1999
-$213.00 K(-109.9%)
-
Dec 1998
$2.15 M(+6.5%)
-
Dec 1997
$2.02 M(-63.8%)
-
Dec 1996
$5.57 M
-

FAQ

  • What is Medifast annual stockholders equity?
  • What is the all time high annual shareholders equity for Medifast?
  • What is Medifast annual shareholders equity year-on-year change?
  • What is Medifast quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Medifast?
  • What is Medifast quarterly shareholders equity year-on-year change?

What is Medifast annual stockholders equity?

The current annual shareholders equity of MED is $210.11 M

What is the all time high annual shareholders equity for Medifast?

Medifast all-time high annual stockholders equity is $210.11 M

What is Medifast annual shareholders equity year-on-year change?

Over the past year, MED annual stockholders equity has changed by +$8.63 M (+4.28%)

What is Medifast quarterly stockholders equity?

The current quarterly shareholders equity of MED is $210.11 M

What is the all time high quarterly shareholders equity for Medifast?

Medifast all-time high quarterly stockholders equity is $216.02 M

What is Medifast quarterly shareholders equity year-on-year change?

Over the past year, MED quarterly stockholders equity has changed by $0.00 (0.00%)